Trials / Completed
CompletedNCT02011893
SUNBURST (Success Using Neuromodulation With BURST) Study
Success Using Neuromodulation With BURST (SUNBURST™) Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for the treatment of chronic intractable pain of the trunk and/or limbs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tonic Stimulation | Prodigy Neurostimulation System with associated components |
| DEVICE | Burst Stimulation | Prodigy Neurostimulation System with associated components |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2016-01-01
- Completion
- 2017-01-01
- First posted
- 2013-12-13
- Last updated
- 2019-01-30
- Results posted
- 2017-05-18
Locations
20 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02011893. Inclusion in this directory is not an endorsement.